Index exclusion puts Sotera Health in focus

Sotera Health (SHC) has been dropped from several Russell growth benchmarks, including the Russell 1000 Growth and Russell 3000 Growth indexes, a shift that can influence passive fund positioning and short term trading flows.

For Sotera Health, the index removal arrives just as momentum has started to build again, with a 7 day share price return of 12.06% and a 90 day share price return of 19.37%, while the 1 year total shareholder return of 55.02% contrasts with weaker multi year total shareholder returns.

If this kind of index driven volatility has you reassessing your watchlist, it could be a good moment to see what else is moving and scan 40 healthcare AI stocks.

With Sotera Health trading at $17.75, sitting at a discount to both analyst price targets and some intrinsic value estimates, the key question is whether investors are getting a bargain or if the stock already reflects future growth.

Most Popular Narrative: 12.2% Undervalued

On the most followed narrative, Sotera Health screens as undervalued, with a modeled fair value of $20.22 versus the recent $17.75 close. That gap rests on some firm operational assumptions.

The extension in the EPA's EtO regulations implementation timeframe, combined with Sotera Health's proactive compliance investments, positions the company to benefit from stricter global patient safety standards by providing compliant, outsourced sterilization solutions, supporting both topline growth and earnings resilience as regulatory requirements increase.

Want to see what is baked into that fair value for Sotera Health? The narrative leans on steady top line expansion, sharply higher margins, and a richer earnings base that supports today’s pricing assumptions.

Result: Fair Value of $20.22 (UNDERVALUED)

However, Sotera Health still faces meaningful risks, including tighter ethylene oxide rules that could raise costs and high compliance and CapEx needs that pressure cash generation.

Next Steps

Given the mixed sentiment around Sotera Health, with both risks and rewards in play, it may be useful to move quickly and test the data yourself by reviewing the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Sotera Health?

If you are serious about building a stronger portfolio, do not stop at Sotera Health. Use the Simply Wall St Screener to source fresh, data backed ideas.

• Target higher potential upside by scanning screener containing 19 high quality undiscovered gems that combine solid fundamentals with lower market attention.
• Strengthen your income stream by reviewing 10 dividend fortresses that focus on companies with higher yields and support from underlying cash flows.
• Dial down portfolio risk by checking 74 resilient stocks with low risk scores that highlight companies with more resilient financial profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.